DZ2479A1 - Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. - Google Patents

Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Info

Publication number: DZ2479A1
Authority: DZ; Algeria
Prior art keywords: pharmaceutical compositions; compositions containing; inhibitor compounds; inflammatory selective; inflammatory
Prior art date: 1997-05-05

Application number

DZ980089A

Other languages

English (en)

Inventor

Kristin Marie Lundy

Anthony Paul Ricketts

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1998-03-02

Publication date

2003-02-01

1998-03-02 Application filed by Pfizer filed Critical Pfizer

2003-02-01 Application granted granted Critical

2003-02-01 Publication of DZ2479A1 publication Critical patent/DZ2479A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

DZ980089A 1997-05-05 1998-03-02 Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. DZ2479A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05

Publications (1)

Publication Number	Publication Date
DZ2479A1 true DZ2479A1 (fr)	2003-02-01

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ980089A DZ2479A1 (fr)	1997-05-05	1998-03-02	Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (fr)
JP (1)	JP2000513020A (fr)
KR (2)	KR20040004406A (fr)
CN (1)	CN1255059A (fr)
AP (1)	AP9801234A0 (fr)
AR (2)	AR011726A1 (fr)
AU (1)	AU6932198A (fr)
BG (1)	BG103852A (fr)
BR (1)	BR9808720A (fr)
CA (1)	CA2288759A1 (fr)
DZ (1)	DZ2479A1 (fr)
EA (1)	EA003696B1 (fr)
GT (1)	GT199800063A (fr)
HR (1)	HRP980244A2 (fr)
HU (1)	HUP0001286A3 (fr)
ID (1)	ID21311A (fr)
IL (1)	IL132570A0 (fr)
IS (1)	IS5220A (fr)
MA (1)	MA26491A1 (fr)
NO (1)	NO995389L (fr)
NZ (1)	NZ500183A (fr)
OA (1)	OA11213A (fr)
PA (1)	PA8450601A1 (fr)
PE (1)	PE72599A1 (fr)
PL (1)	PL337003A1 (fr)
SK (1)	SK148199A3 (fr)
TN (1)	TNSN98059A1 (fr)
TW (1)	TW590773B (fr)
UY (1)	UY24989A1 (fr)
WO (1)	WO1998050033A1 (fr)
YU (1)	YU55899A (fr)
ZA (1)	ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) *	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) *	1998-10-23	2003-09-04	Merck Frosst Canada & Co.	Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
ES2249253T3 (es) *	1999-03-10	2006-04-01	G.D. Searle Llc	Metodo y composicion para administrar un inhibidor de la ciclooxigenasa-2.
AU1592901A (en) *	1999-11-11	2001-06-06	Eli Lilly And Company	Oncolytic combinations for the treatment of cancer
WO2001087343A2 (fr) *	2000-05-15	2001-11-22	Merck Frosst Canada & Co.	Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
AU6837701A (en)	2000-06-13	2001-12-24	American Home Prod	Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (de) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
CA2422803A1 (fr)	2000-08-07	2002-02-14	Vanderbilt University	Detection de l'activite cox-2 et des metabolites d'anandamide
WO2003007875A2 (fr) *	2001-07-16	2003-01-30	Hoegestaett Edward	Substances organoleptiques d'acetaminophene et composes associes utilises comme substrats pour conjugaison d'acides gras et utilisation de ces substances dans le traitement de la douleur, de la fievre et des inflammations
ES2275218T3 (es)	2003-05-07	2007-06-01	Osteologix A/S	Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
KR100780983B1 (ko) *	2003-07-31	2007-11-30	파마시아 앤드 업존 캄파니 엘엘씨	소염제의 분산성 제제
WO2006123247A2 (fr) *	2005-05-20	2006-11-23	Pfizer Limited	Combinaisons synergiques
EP2380564B1 (fr)	2007-04-04	2014-10-22	Sigmoid Pharma Limited	Composition pharmaceutique orale
JP2010527285A (ja)	2007-04-26	2010-08-12	シグモイド・ファーマ・リミテッド	複数のミニカプセルの製造
CN105213318A (zh)	2009-05-18	2016-01-06	希格默伊德药业有限公司	包含油滴的组合物
CN102573802A (zh)	2009-08-12	2012-07-11	希格默伊德药业有限公司	包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
WO2015134792A1 (fr) *	2014-03-06	2015-09-11	Aratana Therapeutics, Inc.	Compositions de grapiprant et ses procédés d'utilisation
DK3215127T3 (da)	2014-11-07	2021-02-01	Sublimity Therapeutics Ltd	Sammensætninger omfattende cyclosporin
WO2016112312A1 (fr) *	2015-01-09	2016-07-14	Jaguar Animal Health	Méthodes de traitement de la diarrhée chez des animaux de compagnie
US20230174485A1 (en) *	2020-03-25	2023-06-08	Sri International	Lipoxygenase inhibitors
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (fr) *	1987-02-03	1993-07-06	Alberto Ferro	Solutions de micelles mixtes

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/fr active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Ceased
- 1998-05-01 EP EP98915041A patent/EP0988034A1/fr not_active Withdrawn
- 1998-05-01 CA CA002288759A patent/CA2288759A1/fr not_active Abandoned
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/fr not_active Ceased
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Ceased
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown

Also Published As

Publication number	Publication date
CN1255059A (zh)	2000-05-31
IL132570A0 (en)	2001-03-19
AU6932198A (en)	1998-11-27
PA8450601A1 (es)	2000-05-24
KR20040004406A (ko)	2004-01-13
UY24989A1 (es)	2001-10-25
TNSN98059A1 (fr)	2005-03-15
WO1998050033A1 (fr)	1998-11-12
YU55899A (sh)	2003-08-29
IS5220A (is)	1999-10-19
TW590773B (en)	2004-06-11
GT199800063A (es)	1999-10-26
NO995389L (no)	2000-01-04
PL337003A1 (en)	2000-07-31
ZA983722B (en)	1999-11-04
HUP0001286A2 (hu)	2000-11-28
SK148199A3 (en)	2001-09-11
NZ500183A (en)	2002-04-26
MA26491A1 (fr)	2004-12-20
AR039628A2 (es)	2005-03-02
EA003696B1 (ru)	2003-08-28
JP2000513020A (ja)	2000-10-03
OA11213A (en)	2003-07-14
ID21311A (id)	1999-05-20
BG103852A (en)	2000-06-30
EA199900895A1 (ru)	2000-06-26
HRP980244A2 (en)	1999-02-28
KR20010012300A (ko)	2001-02-15
CA2288759A1 (fr)	1998-11-12
AR011726A1 (es)	2000-08-30
HUP0001286A3 (en)	2000-12-28
PE72599A1 (es)	1999-08-12
AP9801234A0 (en)	1999-11-04
BR9808720A (pt)	2000-07-11
EP0988034A1 (fr)	2000-03-29
NO995389D0 (no)	1999-11-04

Publication	Publication Date	Title
DZ2479A1 (fr)	2003-02-01	Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
DZ1916A1 (fr)	2002-02-17	Composés nouveaux et compostions pharmaceutiques les contenant.
DZ2086A1 (fr)	2002-07-22	Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
DZ2964A1 (fr)	2004-03-15	Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
DZ2461A1 (fr)	2003-01-18	Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
MA26553A1 (fr)	2004-12-20	Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
MA26537A1 (fr)	2004-12-20	Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
DZ2361A1 (fr)	2002-12-28	Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
DZ2494A1 (fr)	2003-01-25	Composition pharmaceutique d'oméprazole.
MA26548A1 (fr)	2004-12-20	Compositions pharmaceutiques topiques contenant des derives de resorcinol.
MA24466A1 (fr)	1998-10-01	Compositions contenant de la tetrahydrolistatine
DZ3191A1 (fr)	2001-01-11	Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
DZ2978A1 (fr)	2004-07-04	Composés chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
CY2012029I1 (el)	2015-08-05	Νεα μορφη της s-ομεπραζολης
DZ2686A1 (fr)	2003-03-29	Formulation pharmaceutique orale à libération pulsée.
FR2775596B1 (fr)	2004-12-24	Nouvelles compositions pharmaceutiques
BR1100403A (pt)	2000-07-25	Composto e composição farmacêutica de inibidores de cox-2
NO980546D0 (no)	1998-02-09	Farmasöytiske midler
MA26492A1 (fr)	2004-12-20	Inhibiteurs de proteases nouveaux et compositions pharmaceutiques les contenant .
MA26486A1 (fr)	2004-12-20	Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
ATE268758T1 (de)	2004-06-15	Hypolipidämische propanolaminderivate
DZ2609A1 (fr)	2003-03-01	Composés nouveaux antagonistes des récepteurs de vitronectine et compositions pharmaceutiques les contenant.
FR2773801B1 (fr)	2000-05-12	Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
ID29294A (id)	2001-08-16	Komposisi farmasi
MA26531A1 (fr)	2004-12-20	Composition pharmaceutique